OESTROGENPERI£2BN CATEGORY · 2026
Industry TrendsBrand Founders3 min read14 March 2026

Perimenopause Beauty Is Now a £2bn Category. Are You Positioned For It?

Perimenopause and menopause skincare has moved from niche to mainstream in under three years. Here's what the data says and what it means for the ops side of your brand.

SL
Sophie Lansbury

Beauty 2.0 Founder - 20 years in the beauty industry

If you want a piece of this category, your formulation claims, your photography, and your packaging copy all need to be rebuilt for a customer who can spot generic 'anti-ageing' marketing from a mile away.

Key takeaway

In brief
Why perimenopause skincare is the fastest-growing customer segment in beauty right now, and what brands trying to extend into it keep getting wrong.
Who this is for
Brand Founders
Main takeaway
If you want a piece of this category, your formulation claims, your photography, and your packaging copy all need to be rebuilt for a customer who can spot generic 'anti-ageing' marketing from a mile away.
What to do next
Audit whether your brand has a credible 40+ story or whether you are trying to retrofit one. If the second, the honest answer is to build a sub-brand.

Three years ago, "menopause skincare" was a category that existed mostly in press releases. In 2026, it is one of the fastest-growing segments in UK and US beauty, and the brands who moved early are now dealing with the nicer problem of keeping up with demand.

Stripes, State Of, Womaness, and Rosen have all crossed meaningful revenue thresholds. Boots launched a dedicated menopause aisle in late 2025. Space NK has an edit. Sephora's UK stores carry five brands in the space and are adding two more this year.

The growth is real. What most brands trying to enter the category are getting wrong is the assumption that it is just an extension of anti-ageing skincare with a different name on the box.

The customer is not who your media buyer thinks she is

The 40+ customer is not dipping a toe into your existing funnel. She is running a parallel routine, often with different brands, different formats, and different purchase triggers than your existing customer base.

She reads labels. She reads clinical claims. She can tell the difference between a product formulated for perimenopausal skin (estrogen loss, barrier compromise, oil reduction, sudden sensitivity) and a product that was relabelled with "menopause-friendly" marketing and pushed through the same Meta creative.

If your current top-selling SKU is a 25-year-old's hydrating serum and you are trying to extend it with a 55-year-old's copy, she will not buy it. She will buy from a brand whose whole stack was built for her.

What to actually check before you enter

Three honest questions.

One. Does your current formulation hold up to scrutiny? Ingredients that are fine for a 28-year-old barrier can be abrasive for a 52-year-old barrier. If your hero product has fragrance, essential oils, or aggressive acids, you will need a fresh stack.

Two. Does your photography reflect the customer, or does it reflect the customer you wish you had? Most menopause brands have fallen into one of two failure modes: aggressive airbrushing that reads as anti-ageing, or tokenistic grey-haired model shots that feel condescending. The brands that work (Stripes, State Of) show women who look like their actual customers without apologising for it.

Three. Is your packaging copy written for someone who is tired, dismissed by their GP, and researching at 2am? Or is it written for Instagram? This customer does not need another aesthetic. She needs to trust the brand in a way she has not trusted beauty for the past decade.

The honest path forward

If your brand has a credible story for this customer, tell it. If it does not, the honest answer is a sub-brand, not a repositioning. Almay tried to pivot to menopause. It did not work. Estée Lauder built a dedicated line (Revitalift Pro XR). It did.

The operational cost of getting this wrong is not just the failed launch. It is the damage to your core brand from marketing that felt opportunistic to your existing customer. Get it right, or stay out.

Share
SL

Sophie Lansbury

Founder of Beauty 2.0. Nearly 20 years in beauty — from counter to boardroom, indie launches to global houses. Writes about the operational reality of growing beauty brands.

About Sophie
“

The 40+ customer is not a demographic extension - she is a category in her own right, and she does not shop the way your existing customer does.

Was this helpful?

Related posts

THE SUPPLY CHAIN YOU CANNOT SEESUPPLIER ASUPPLIER BYOUR CONTRACT MANUFACTURERYOUR BRANDPRICE UPMOQ UPREFORMULATE?NO LABELON THE CAUSE
Industry TrendsBrand FoundersEU5 min read

BASF Has Bid €10.3bn for Evonik. Two of the Biggest Suppliers of Your Formula's Ingredients May Become One.

Personal Care Insights reported on 29 September that BASF has confirmed exploratory talks to acquire Evonik, with an opening offer of €22.15 per share valuing the equity at €10.3bn and the enterprise at €14.2bn, which Evonik reportedly rejected as too low. Both supply actives, emollients and surfactants that end up in small brands' formulas through contract manufacturers. Consolidation upstream reaches you late, indirectly, and without warning.

5 Oct 2026Read →
WHAT GETS YOU THE SHELFRETAILER BEAUTY FIXTUREPRODUCTBEAUTY BRANDPRODUCTLIFESTYLE BRAND + ITS AUDIENCEFOOTFALL WINS TIES
Industry TrendsBrand FoundersUK5 min read

Sweaty Betty and Bella Freud Both Launched Beauty Through Boots This Month. Neither Is a Beauty Brand.

Global Cosmetics News reported Sweaty Betty's Beauty and Wellness Collection on 21 September and Bella Freud's Glamorama collection on 25 September, both launching exclusively through Boots. Two adjacent-category brands entering beauty through the same retailer in the same week is a pattern rather than a coincidence, and it says something uncomfortable about what a retailer values when choosing who to back.

27 Sept 2026Read →
MINORITY 2022, MAJORITY 202620222026MINORITY STAKEMAJORITY STAKEFOUR YEARSDISTRIBUTION, NOT JUST CASHFOUNDER KEEPS EQUITY AND THE CHAIR
Industry TrendsBrand FoundersEU5 min read

Caudalie Took a Minority Stake in Talm in 2022 and the Majority in 2026. The Founder Kept Equity and Stayed CEO.

Global Cosmetics News reported on 15 September that Caudalie has acquired a majority stake in French skincare brand Talm, its first ever acquisition of another brand. Founder Kenza Keller retains a minority stake and continues as chief executive. Talm has 12 products across roughly 60 doors in 12 countries. The four-year path from minority investment to majority is a deal shape that suits brands at exactly this size, and most founders have never considered it.

20 Sept 2026Read →